U.S. medical device maker Edwards Lifesciences narrowly topped Wall Street estimates for quarterly revenue on Thursday as it sold more heart monitors, but its outlook for March quarter earnings fell below analysts' forecasts.
from Reuters: Health News https://reut.rs/2GdI29W
via IFTTT
from Reuters: Health News https://reut.rs/2GdI29W
via IFTTT
إرسال تعليق